SCHEMBL30425848

SCHEMBL30425848

Cc1cccc[n+]1-c1ccccc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 3/20 0.48
HTT P42858 2/20 0.48
MAPT P10636 1/20 0.48
CA12 O43570 1/20 0.41
CA1 P00915 1/20 0.41
CA2 P00918 1/20 0.41
CA9 Q16790 1/20 0.41
CA14 Q9ULX7 1/20 0.41
RAB9A P51151 4/20 0.39
NPC1 O15118 3/20 0.39
POLB P06746 2/20 0.39
GFER P55789 1/20 0.35
TSHR P16473 2/20 0.35
ACHE P22303 2/20 0.35
LMNA P02545 1/20 0.35
ALOX12 P18054 1/20 0.35
BCL2 P10415 1/20 0.33
KDM4E B2RXH2 2/20 0.32
SLC22A2 O15244 1/20 0.32
SLC22A1 O15245 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1263770 1.00 SMN1; SMN2 (0.48) SMN1; SMN2HTTMAPTCA12CA1
Hydrochloric Acid SCHEMBL636847 1.00 SMN1; SMN2 (0.48) SMN1; SMN2HTTMAPTCA12CA1
Bromide SCHEMBL637005 0.98 SMN1; SMN2 (0.47) SMN1; SMN2HTTMAPTCA12CA1
SCHEMBL7262939 0.82 CA12 (0.37) SMN1; SMN2HTTMAPTCA12CA1
Hydrochloric Acid SCHEMBL28754080 0.73 MAPT (0.38) SMN1; SMN2HTTMAPTTSHRBCL2
Hydrochloric Acid SCHEMBL6702513 0.73 SMN1; SMN2 (0.39) SMN1; SMN2HTTMAPTCA12CA1
Hydrochloric Acid SCHEMBL10708206 0.73 HDAC8 (0.40) SMN1; SMN2HTTMAPTCA12CA1
SCHEMBL26186710 0.72 CA12 (0.43) SMN1; SMN2CA12CA1CA2CA9
SCHEMBL25530877 0.72 CA12 (0.37) SMN1; SMN2HTTMAPTCA12CA1
SCHEMBL26806792 0.71 CA12 (0.46) SMN1; SMN2CA12CA1CA2CA9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025040166-A1 PHARMACEUTICAL COMPOSITION AND USE THEREOF 上海瑞宏迪医药有限公司 2025-02-27 WO disclosed
WO-2023093905-A1 AADC/GDNF POLYNUCLEOTIDE, AND USE THEREOF IN TREATING PARKINSON'S DISEASE 上海瑞宏迪医药有限公司 2023-06-01 WO disclosed